Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,586 total articles
Outlook Therapeutics (OTLK) is a clinical-stage ophthalmic firm whose LYTENAVA (ONS-5010) has EU approval and a pending UK filing but faces FDA hurdles and chronic funding needs. Recent at-the-market financing, warrant amendments and elevated short interest create a tradable setup: a long position targeting a regulatory/financing-driven re-rating o…
Bank of America (BAC) looks set to continue a technical run: price above key SMAs/EMAs, bullish MACD, RSI in healthy territory, and a cheap P/E with a sticky $951B deposit franchise. I outline an actionable long trade with entry, stop, and target, the catalysts to watch, and the risks that would flip my view.
Quanta Services (PWR) is the contractor the grid needs: record backlog, expanding margins on fixed-price work, and direct exposure to electrification and data-center buildouts. The stock has sold off intraday; we view this as a tactical entry for a mid-term trade. Key risks include stretched valuation, execution on large projects, and customer cape…
SaaS multiple compression has knocked Shopify back to levels that look attractive for a measured, risk-managed long. Management just doubled down on buybacks, liquidity is healthy, and technicals are stabilizing. This trade idea outlines entry, stop and a mid-term target tied to a realistic re-rating and operational tailwinds.
Scorpio Tankers (STNG) has strengthened its balance sheet through asset sales, long-term charters and convertible note financing that funded sizable buybacks. Those moves materially improve earnings visibility and shareholder returns, but the stock's rally toward a $3.93B market cap and a PE of ~7x has removed much of the cheapness that attracted i…
Medtronic's latest quarter showed durable top-line momentum across Cardiovascular and Diabetes while one-off items compressed margins. The fundamentals and cash flow support a buy here; technicals show constructive momentum. This is a mid-term swing trade that leans on continued margin normalization and Diabetes product tailwinds.
Arteris (AIP) is a niche network-on-chip (NoC) IP vendor that has quietly earned design wins with AMD, Li Auto and other AI and automotive chip customers. The stock has run up from its 2025 lows, but current pullbacks create a defined-risk entry into a company that could see meaningful revenue leverage as hyperscalers and chipmakers adopt chiplet a…
Nano Labs trades at a sub-$50M market cap with a PE of 2.23 and a PB of 0.46 after a strategic pivot into AI infrastructure and cryptocurrency reserves. Recent corporate actions — an MoU to evaluate North American AI data centers, a tokenization initiative on BNB Chain, and insider buying — provide tangible catalysts. The stock is volatile and thin…
Lockheed Martin (LMT) is a high-quality defense cash machine trading at $523.91 with a compelling risk/reward for a mid-term swing trade. Strong free cash flow ($5.66B), a healthy backlog across Aeronautics and Space, and recent program wins create a buyable setup. Entry $520, stop $495, target $590 over ~45 trading days.
Arista Networks sold off sharply after recent results despite solid fundamentals and continued AI data-center demand. The pullback creates an attractive, defined-risk swing trade: enter near the current pullback, place a tight stop below the technical support band, and target the multi-month resistance set by analyst optimism and the company’s 52-w…
Credo just guided to an optical business north of $600M for fiscal 2027 and Q1 revenue of $465-475M. That guidance is the catalyst — not the headline revenue figure itself. This trade buys the credibility of management's forward outlook after a beat, with a mid-term (45 trading days) target near the recent 52-week high. Tight stop to limit exposure…
CoreWeave has validated next-gen Nvidia racks and sits on a reported $99.4B backlog while Nvidia has increased its stake to roughly 9%. The market is punishing the stock for leverage and negative cash flow, leaving an entry opportunity for disciplined, risk-aware longs. This trade idea lays out an entry at $100.40, a stop at $82.00 and a mid-term t…
Arista Networks (ANET) sold off after Q1 results, pulling the stock into the mid-$150s. At ~52x trailing EPS the valuation looks rich at first glance, but strong profitability (37.8% net margin), high ROE (27.6%), $5.3B in free cash flow and an $8.9B backlog argue the multiple is pricing in durable AI data-center growth rather than froth. This trad…
Alphabet's $80 billion equity raise and a sizable check from Berkshire Hathaway crystallize a path to scale the company's AI infrastructure. With $64.4B in free cash flow, a $4.43T market cap and healthy returns on equity, Alphabet looks positioned to convert heavy AI spending into durable growth. This trade plan targets a measured long with define…
Henkel's share price reflects a company with slowing growth but durable cash generation. We favor a mid-term long trade that captures valuation re-rating and near-term catalysts (cost saves, buybacks, FX) while protecting capital with a defined stop.
Arista Networks is uniquely positioned to profit from the current AI infrastructure buildout. Recent earnings triggered a >10% sell-off that created a mid-term buying opportunity. We outline an actionable long trade with entry, stop, and target, plus catalysts and risks tied to margin and supply dynamics.
Northeast Community Bancorp (NECB) is a small-cap community bank trading below book and at a single-digit P/E after a solid Q1 that showed continued deposit inflows, disciplined credit and a growing construction loan pipeline. With strategic deposit restructuring lowering funding costs and a sizeable unfunded commitments backlog, NECB looks positio…
Wolters Kluwer (WTKWY) trades at $72.67 with a market cap near $16.9B, a P/E of ~11.7 and a 3.37% yield. Management has repurchased ~2.36M shares year-to-date under a 500 million buyback program and is scaling engineering capacity in India for AI-enabled product development. We upgrade to a long - the combination of active capital return, recurring…
Nano Labs (NA) trades at a sub-$50M market cap after a painful drawdown and meaningful corporate restructuring. With CEO open-market buying, a 53.5% cut to operating expenses, a strategic MoU for North American AI infrastructure, and a thin float that magnifies moves, the stock looks actionable on a mid-term long trade. Entry $2.15, stop $1.70, tar…
Birchcliff Energy (BIREF) trades at $4.63 with a market cap of roughly $1.27B. With a sub-1.0 P/B, a modest dividend and elevated short interest, the stock is positioned for a mid-term rebound if management can deliver measurable efficiency gains. We upgrade to a tactical long and lay out an entry, stop and target with a 45-trading-day thesis.
Rubrik reported a clean quarter on 06/04/2026 with revenue of $387.07M, an EPS surprise, and raised fiscal 2027 guidance. The company is converting strong top-line growth into free cash flow and improving margins while building partner-led distribution that increases customer stickiness. Given improving fundamentals, constructive technicals and a c…
Murphy Oil (MUR) looks primed for a mid-term run as recent asset rationalization and a $125M FPSO purchase that trims $60M of annual operating costs combine with neutral-to-positive technicals and a tidy balance sheet. At a market cap near $5.6B and free cash flow of $178M, the stock can re-rate if oil stays elevated and production execution holds.
Syntec Optics (OPTX) just closed a major liquidity overhang via a $20M at-the-market style public offering and looks set to benefit from Russell 3000 reconstitution flows. Fundamentals remain early-stage – Q3 2025 revenue was $7.0M and gross margins are improving – but balance-sheet relief plus technical momentum make a tactical buy. I maintain Buy…
Mayville Engineering (MEC) has ripped to a $33.50 52-week high on strong momentum, but the fundamentals don't support a frothy multiple. Negative EPS, weak returns, modest free cash flow of $14.6M and an EV/EBITDA near 33x make the stock vulnerable to a mid-term mean reversion. This trade idea lays out a measurable short with entry, stop and target…
<p>WeRide is a high-beta autonomous-vehicle (AV) name where the next leg higher will come from two things: visible regulatory approvals in new cities and revenue-bearing pilots outside its home market. The stock has been rangebound while investors wait for tangible commercialization milestones. This trade idea targets a tactical long with a clear s…
